From L-R: Zavain Dar, Adam Goulburn and Nan Li (Dimension)
January 25, 2023 07:00 AM EST
Financing
Startups

‘Silo­ing is just so out­dat­ed’: New $350M VC fund aims to dig­i­tize life sci­ences

Kyle LaHucik

Senior Reporter

As tech­nol­o­gy in­creas­ing­ly helps find drug tar­gets, en­hance the di­ag­no­sis of dis­eases, speed up the test­ing of new ther­a­peu­tics and es­sen­tial­ly an­gle its way in­to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

NewAms­ter­dam aces Phase 3 tri­al, but in­vestors are skep­ti­cal

Post-Hoc: RFK vs. Vivek, and the fu­ture of US drug pol­i­cy

FDA up­dates la­bel of 33-year-old can­cer drug with new dose and warn­ing

Pfiz­er part­ners with two more Flag­ship biotechs on obe­si­ty, can­cer

When gen­er­a­tive AI meets the FDA: First dig­i­tal health ad­comm kicks off dis­cus­sion

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times